Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Francois Tanguay

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Journal of Clinical Medicine|July 24, 2021
Misreported Cancer Deaths in PLATO TrialVictor Serebruany, Jean-Francois Tanguay
Reviews in Cardiovascular Medicine|September 26, 2021
FDA PLATO deaths list challenges aspirin dose-ticagrelor interactionVictor Serebruany, Jean-Francois Tanguay
TH Open : Companion Journal to Thrombosis and Haemostasis|November 12, 2021
Infections Deaths in the PLATO TrialVictor Serebruany, Jean-Francois Tanguay
Expert Review of Cardiovascular Therapy|September 18, 2007
Antiplatelet therapy in the era of drug-eluting stents: current and future perspectivesGregory Ducrocq, Victor Serebruany, Jean-Francois Tanguay
Reviews in Cardiovascular Medicine|July 30, 2024
Primary Causes of Death Reported to the FDA Suggest Less Ticagrelor Mortality Benefit than the List Issued to the PLATO Trial InvestigatorsVictor Serebruany, Jean-Francois Tanguay, Thomas Marciniak
International Journal of Clinical Practice|March 6, 2021
The FDA and PLATO Investigators death lists: Call for a matchVictor L Serebruany, Jean-Francois Tanguay, Thomas A Marciniak
Journal of Pharmacological and Toxicological Methods|June 26, 2007
A cardiovascular monitoring system used in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 2: Pharmacological validationSimon Authier, Jean-Francois Tanguay, Dominique Gauvin, et al.
Discoveries (Craiova, Romania)|February 26, 2024
Impact of the reporting source on Platelet Inhibition and Treatment Outcomes (PLATO) trial deathsVictor Serebruany, Jean-Francois Tanguay, Hector A Cabrera-Fuentes, et al.
American Journal of Therapeutics|September 15, 2023
Strokes and Transient Ischemic Attacks Occurrence During Annual Dual Antiplatelet TherapyVictor L Serebruany, Jean-Francois Tanguay, Milana L Gurvich, et al.
The American Journal of Medicine|February 24, 2023
Time Course of Death After Acute Coronary Syndrome Treated With Dual Antiplatelet Therapy for 1 YearVictor L Serebruany, Jean-Francois Tanguay, Milana L Gurvich, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|July 24, 2021
Misreported Cancer Deaths in PLATO TrialVictor Serebruany, Jean-Francois Tanguay
Reviews in Cardiovascular Medicine|September 26, 2021
FDA PLATO deaths list challenges aspirin dose-ticagrelor interactionVictor Serebruany, Jean-Francois Tanguay
TH Open : Companion Journal to Thrombosis and Haemostasis|November 12, 2021
Infections Deaths in the PLATO TrialVictor Serebruany, Jean-Francois Tanguay
Expert Review of Cardiovascular Therapy|September 18, 2007
Antiplatelet therapy in the era of drug-eluting stents: current and future perspectivesGregory Ducrocq, Victor Serebruany, Jean-Francois Tanguay
Reviews in Cardiovascular Medicine|July 30, 2024
Primary Causes of Death Reported to the FDA Suggest Less Ticagrelor Mortality Benefit than the List Issued to the PLATO Trial InvestigatorsVictor Serebruany, Jean-Francois Tanguay, Thomas Marciniak
International Journal of Clinical Practice|March 6, 2021
The FDA and PLATO Investigators death lists: Call for a matchVictor L Serebruany, Jean-Francois Tanguay, Thomas A Marciniak
Journal of Pharmacological and Toxicological Methods|June 26, 2007
A cardiovascular monitoring system used in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 2: Pharmacological validationSimon Authier, Jean-Francois Tanguay, Dominique Gauvin, et al.
Discoveries (Craiova, Romania)|February 26, 2024
Impact of the reporting source on Platelet Inhibition and Treatment Outcomes (PLATO) trial deathsVictor Serebruany, Jean-Francois Tanguay, Hector A Cabrera-Fuentes, et al.
American Journal of Therapeutics|September 15, 2023
Strokes and Transient Ischemic Attacks Occurrence During Annual Dual Antiplatelet TherapyVictor L Serebruany, Jean-Francois Tanguay, Milana L Gurvich, et al.
The American Journal of Medicine|February 24, 2023
Time Course of Death After Acute Coronary Syndrome Treated With Dual Antiplatelet Therapy for 1 YearVictor L Serebruany, Jean-Francois Tanguay, Milana L Gurvich, et al.
Pageof 8